www.fdanews.com/articles/148828-abbott-announces-ce-mark-european-launch-of-next-generation-xience-xpedition-drug-eluting-stent

Abbott Announces CE Mark, European Launch of Next-Generation XIENCE Xpedition Drug Eluting Stent

August 20, 2012

Abbott announced that the XIENCE Xpedition Everolimus Eluting Coronary Stent System received CE Mark in Europe for the treatment of coronary artery disease.
The Sacramento Bee